Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 10/01/25
Akero Therapeutics, Inc. (AKRO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 08/28/25
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare ConferenceGlobeNewsWire • 08/28/25
Does Akero Therapeutics (AKRO) Have the Potential to Rally 59.14% as Wall Street Analysts Expect?Zacks Investment Research • 08/27/25
Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASHGlobeNewsWire • 08/14/25
Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 08/08/25
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities InvestigationAccesswire • 06/08/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to ConnectAccesswire • 06/05/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Reach OutAccesswire • 06/03/25
Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewsWire • 06/03/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the InvestigationAccesswire • 06/01/25
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities InvestigationAccesswire • 05/29/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Investors to Learn More About the InvestigationAccesswire • 05/27/25
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 05/25/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Investors to ConnectAccesswire • 05/22/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Reach OutAccesswire • 05/18/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to ConnectAccesswire • 05/15/25
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 05/13/25
Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/12/25